OM — Outset Medical Cashflow Statement
0.000.00%
- $199.13m
- $169.03m
- $130.38m
- 34
- 33
- 39
- 27
Annual cashflow statement for Outset Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -68.3 | -121 | -132 | -163 | -173 |
Depreciation | |||||
Non-Cash Items | -1.88 | 25.2 | 22.1 | 33.2 | 36.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.6 | -5.85 | -25.6 | -21.1 | -0.773 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -70.3 | -99 | -130 | -146 | -131 |
Capital Expenditures | -3.29 | -9.11 | -3.11 | -8.32 | -3.44 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 77.6 | 13.1 | -139 | -58 | 86.5 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 74.3 | 3.95 | -143 | -66.3 | 83 |
Financing Cash Flow Items | -0.181 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.249 | 386 | 160 | 72.9 | 43.7 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.25 | 291 | -113 | -139 | -4.7 |